The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis
Open accessAbstract
BACKGROUND: Numerous observational studies suggest that preventable adverse drug reactions are a significant burden in healthcare, but no meta-analysis using a standardised definition for adverse drug reactions exists. The aim of the study was to estimate the percentage of patients with preventable adverse drug reactions and the preventability of adverse drug reactions in adult outpatients and inpatients. METHODS: Studies were identified through searching Cochrane, CINAHL, EMBASE, IPA, Medline, PsycINFO and Web of Science in September 2010, and by hand searching the reference lists of identified papers. Original peer-reviewed research articles in English that defined adverse drug reactions according to WHO's or similar definition and assessed preventability were included. Disease or treatment specific studies were excluded. Meta-analysis on the percentage of patients with preventable adverse drug reactions and the preventability of adverse drug reactions was conducted. RESULTS: Data were analysed from 16 original studies on outpatients with 48797 emergency visits or hospital admissions and from 8 studies involving 24128 inpatients. No studies in primary care were identified. Among adult outpatients, 2.0% (95% confidence interval (CI): 1.2-3.2%) had preventable adverse drug reactions and 52% (95% CI: 42-62%) of adverse drug reactions were preventable. Among inpatients, 1.6% (95% CI: 0.1-51%) had preventable adverse drug reactions and 45% (95% CI: 33-58%) of adverse drug reactions were preventable. CONCLUSIONS: This meta-analysis corroborates that preventable adverse drug reactions are a significant burden to healthcare among adult outpatients. Among both outpatients and inpatients, approximately half of adverse drug reactions are preventable, demonstrating that further evidence on prevention strategies is required. The percentage of patients with preventable adverse drug reactions among inpatients and in primary care is largely unknown and should be investigated in future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Leape, L. L. (1994) · PubMed · Cited by 1,961
The incidence and nature of in-hospital adverse events: a systematic review
de Vries, E. N., Ramrattan, M. A., Smorenburg, S. M., Gouma, D. J., & Boermeester, M. A. (2008) · Quality and Safety in Health Care · doi:10.1136/qshc.2007.023622 · Cited by 1,784
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J., Debellis, K., Seger, A. C., Cadoret, C., Fish, L. S., Garber, L., Kelleher, M., et al. (2003) · JAMA · doi:10.1001/jama.289.9.1107 · Cited by 1,676
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Leape, L. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520230061039 · Cited by 1,425
Brown, A. B., & Patterson, D. A. (2001) · Cited by 1,390
Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.
BEIJER, H. J. M., & Blaey, C. J. D. (2002) · Pharmacy World & Science · doi:10.1023/a:1015570104121 · Cited by 916
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Davies, E. C., Green, C. F., Taylor, S., Williamson, P. R., Mottram, D. R., & Pirmohamed, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004439 · Cited by 692
Kongkaew, C., Noyce, P. R., & Ashcroft, D. M. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l037 · Cited by 633
Drug-Related Problems in Hospitals: A Review of the Recent Literature
Kr??henb??hl-Melcher, A., Schlienger, R., Lampert, M., Haschke, M., Drewe, J., & Kr??henb??hl, S. (2007) · Drug Safety · doi:10.2165/00002018-200730050-00003 · Cited by 540
Drug-Related Hospital Admissions
Einarson, T. R. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700702 · Cited by 518
Adverse drug events as a cause of hospital admission in the elderly
Chan, M., Nicklason, F., & Vial, J. H. (2001) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2001.00044.x · Cited by 408
Thomsen, L. A., Winterstein, A. G., S⊘ndergaard, B., Haugb⊘lle, L. S., & Melander, A. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h658 · Cited by 393
The "To Err is Human" report and the patient safety literature
Stelfox, H. T. (2006) · Quality and Safety in Health Care · doi:10.1136/qshc.2006.017947 · Cited by 393
HALLAS, J., HARVALD, B., GRAM, L. F., GRODUM, E., BRØSEN, K., HAGHFELT, T., & DAMSBO, N. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00199.x · Cited by 377
Textbook of Adverse Drug Reactions.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-5-667_1 · Cited by 337
International drug monitoring: the role of national centres. Report of a WHO meeting.
(1972) · PubMed · Cited by 320
Zed, P. J., Abu-Laban, R. B., Balen, R. M., Loewen, P. S., Hohl, C. M., Brubacher, J. R., Wilbur, K., Wiens, M. O., Samoy, L. J., Lacaria, K., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071594 · Cited by 311
Different Patterns of Duplicate Publication: An Analysis of Articles Used in Systematic Reviews
von Elm, E., Poglia, G., Walder, B., & Tramèr, M. R. (2004) · JAMA · doi:10.1001/jama.291.8.974 · Cited by 290
Nature of preventable adverse drug events in hospitals: a literature review
Kanjanarat, P., Winterstein, A. G., Johns, T. E., Hatton, R. C., Gonzalez-Rothi, R., & Segal, R. (2003) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/60.17.1750 · Cited by 277
Royal, S. (2006) · Quality and Safety in Health Care · doi:10.1136/qshc.2004.012153 · Cited by 228
Franceschi, M., Scarcelli, C., Niro, V., Seripa, D., Pazienza, A. M., Pepe, G., Colusso, A. M., Pacilli, L., & Pilotto, A. (2008) · Drug Safety · doi:10.2165/00002018-200831060-00009 · Cited by 221
Drug related admissions to medical wards: a population based survey.
Hallas, J., Gram, L., Grodum, E., Damsbo, N., Brosen, K., Haghfelt, T., Harvald, B., Beck‐ Nielsen, J., Worm, J., & Jensen, K. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04001.x · Cited by 201
Pathogenesis of adverse drug reactions
Rawlins, M. D. (1977) · Medical Entomology and Zoology · Cited by 196
Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs
Dartnell, J., Anderson, R. P., Chohan, V., Galbraith, K. J., Lyon, M. E. H., Nestor, P. J., & Moulds, R. F. W. (1996) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1996.tb122235.x · Cited by 182
Assessing the Economic Impact of Adverse Drug Effects
Rodríguez-Monguió, R., Otero, M. J., & Rovira, J. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321090-00002 · Cited by 177
International drug monitoring: The role of national centres.: (458382004-001)
(1972) · PsycEXTRA Dataset · doi:10.1037/e458382004-001 · Cited by 171
Adverse drug reaction‐related hospitalisations: a population‐based cohort study
van der Hooft, C. S., Dieleman, J. P., Siemes, C., Aarnoudse, A. L. H. J., Verhamme, K. M. C., Stricker, B. H. C. H., & Sturkenboom, M. C. J. M. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1565 · Cited by 169
Patel, K., Kedia, M., Bajpai, D., et al. (2007) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-7-8 · Cited by 150
Winterstein, A. G., Hatton, R. C., Gonzalez‐Rothi, R. J., Johns, T. E., & Segal, R. (2002) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/59.18.1742 · Cited by 136
Readmissions and adverse drug reactions in internal medicine: the economic impact
Dormann, H., Neubert, A. C., Criegee‐Rieck, M., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01326.x · Cited by 127
Medication-Related Visits to the Emergency Department: A Prospective Study
Tafreshi, M. J., Melby, M. J., Kaback, K. R., & Nord, T. C. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.19062 · Cited by 117
Brvar, M., Dovnik, N. F., Bunc, M., & Možina, M. (2009) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-9-8 · Cited by 112
Factors Associated with Preventability, Predictability, and Severity of Adverse Drug Reactions
Gholami, K., & Shalviri, G. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.17440 · Cited by 107
Alexopoulou, A. A., Dourakis, S. P., Mantzoukis, D., et al. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.06.030 · Cited by 103
Leendertse, A. J., Visser, D., Egberts, T. C. G., & van den Bemt, P. M. L. A. (2010) · Drug Safety · doi:10.2165/11319030-000000000-00000 · Cited by 100
Hospital Admissions Due to Adverse Drug Reactions
Levy, M., LIPSHITZ, M., & ELIAKIM, M. (1979) · The American Journal of the Medical Sciences · doi:10.1097/00000441-197901000-00006 · Cited by 100
Factors associated with preventable adverse drug reactions
Pearson, T., Pittman, D. G., Longley, J. M., Grapes, Z. T., Vigliotti, D., & Mullis, S. (1994) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/51.18.2268 · Cited by 93
Dormann, H., Criegee‐Rieck, M., Neubert, A. C., Egger, T., Geise, A., Krebs, S., Schneider, T., Levy, M., Hahn, E. G., & Brune, K. (2003) · Drug Safety · doi:10.2165/00002018-200326050-00004 · Cited by 90
Adverse drug reactions in hospital in-patients: a pilot study
Davies, E. C., Green, C. F., Mottram, D. R., et al. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00744.x · Cited by 87
Preventability of Drug-Related Harms – Part I: A Systematic Review
Ferner, R. E., & Aronson, J. K. (2010) · Drug Safety · doi:10.2165/11538270-000000000-00000 · Cited by 78
Methods for Assessing the Preventability of Adverse Drug Events: A Systematic Review
Hakkarainen, K. M., Sundell, K. A., Petzold, M., & Hägg, S. (2011) · Drug Safety · doi:10.2165/11596570-000000000-00000 · Cited by 75
Self-citationOlivier, P., s, O. B., Tubery, M., Lauque, D., Montastruc, J., & Lapeyre‐Mestre, M. (2002) · Drug Safety · doi:10.2165/00002018-200225140-00005 · Cited by 73
Developing an Adverse Drug Reaction Reporting System at a Teaching Hospital
Baniasadi, S., Fahimi, F., & Shalviri, G. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00217.x · Cited by 73
Adverse-drug-reaction related admissions to a hospital in Scotland
Hopf, Y. M., Watson, M. C., & Williams, D. J. (2008) · Pharmacy World & Science · doi:10.1007/s11096-008-9240-5 · Cited by 47
Farcas, A. M., Sinpetrean, A., Mogoșan, C., Palage, M., Voștinaru, O., Bojita, M. T., & Dumitrascu, D. L. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.05.014 · Cited by 37
Cited by
Tinetti, M. E., McAvay, G., Trentalange, M., Cohen, A. B., & Allore, H. G. (2015) · BMJ · doi:10.1136/bmj.h4984 · Cited by 58
Using machine learning to identify adverse drug effects posing increased risk to women
Chandak, P., & Tatonetti, N. P. (2020) · Patterns · doi:10.1016/j.patter.2020.100108 · Cited by 51
“We downloaded the following: (1) FAERS from openFDA; (2) Gender Specific Adverse Events List from MedDRA; (3) Severity Scores for MedDRA Adverse Events from Table S2 from Gottlieb and colleagues21; (4) Sex Differences in the gene expression from supplementary materials from Yang and Li18; and (5) a vocabulary linking…”
MethodHoulind, M. B., Andersen, A. L., Treldal, C., Jørgensen, L. M., Kannegaard, P. N., Castillo, L. S., Christensen, L. D., Tavenier, J., Rasmussen, L. J. H., Ankarfeldt, M. Z., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020348 · Cited by 48
Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury
Das, S., Behera, S. K., Xavier, A. S., Velupula, S., Dkhar, S. A., & Selvarajan, S. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-017-0601-5 · Cited by 19
Metadata
- Authors
- Hakkarainen, K. M., Hedna, K., Petzold, M., & Hägg, S.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-15
- Volume
- 7
- Issue
- 3
- Pages
- e33236
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2056663596
- Cited by
- 293
- References
- 54
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.